The clinical representative confirmed that the implant procedure was performed in a sterile environment, sterile field handling protocols were used, the procedure was completed in accordance with the product instructions for use, and the sterile barriers of all product used were intact prior to implant.On (b)(6) 2020, cr reported covering case and she stated implanting clinician was implanting sand shark over the lead when he severed lead with bevel of sand shark.He removed the severed lead with no issues and re implanted new lead new sand shark.On (b)(6) 2020, cr contacted complaint specialist on the phone to report that the patient had not been in contact.On (b)(6) 2020, complaint specialist, reviewed sterilization and packaging records for the respective product lots, stimwave has confirmed that the product was delivered sterile, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging for lots swo191113.The stimulator was reported to meet product specifications.Manufacturer cannot currently receive the stimulator for analysis.The device was used for treatment of pain.The device cannot be traced as the source of the issue.
|